Related Experiment Video
Updated: Feb 5, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
Synergistic Effect of F
Kai Liu1, Qingqing Zhang1, Sheng Dai2,3
1School of Chemical Engineering and Technology , Tianjin University , Tianjin 300350 , P. R. China.
Abstract:
A commercial LiNi0.5Co0.2Mn0.3O2 (LNCM) cathode material is purposefully modified using a small account of LiPF6 as one precursor via a simple means at low calcination temperature in air. X-ray diffraction, scanning electron microscopy, and transmission electron microscopy images reveal that this modification process keeps the layered bulk structure of LNCM even though the surface components have obviously been modified. Electron energy loss spectroscopy and X-ray photoelectron spectroscopy with different etching depths further prove the formation of LiF and F- doping on the LNCM surface, which simultaneously triggers partial Ni3+ reduction to Ni2+; and the metal-oxygen bond is partially replaced by a higher energy metal-fluorine bond. The modified material (LNCM-2) retains 93.7% of its initial capacity and delivers 179.4 mAh g-1 at a current density of 0.5 C after 100 stable cycles at 3.0-4.5 V. Meanwhile, LNCM-2 is able to maintain capacity retention up to 81.1% after 300 cycles at 5 C, much better than the original LNCM (35.1%) in the commercial electrolyte. Remarkably, 90% of initial capacity is retained for LNCM-2 with considerably improved Coulombic efficiency (>99.5%) at 5 C after 300 cycles within a voltage range of 3-4.5 V compared with the primary LNCM using succinonitrile-based electrolyte. Consequently, these results fully demonstrate the advantages of synergistic effect between F- doping and LiF coating.
Related Concept Videos
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...

